Work

Plasma IL-6 level and survival of pancreatic cancer patients treated with a VEGFR inhibitor, vatalanib (PTK/ZK)

Year: 2009

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2009.27.15_suppl.e15514

Authors: A. F. Baker, T. Dragovich, A. Cui, D. Laheru, C. Campen, D. D. Von Hoff, M. Hidalgo

Institutions: University of Arizona, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, University of Arizona Cancer Center

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2248823993

Cites:

Cited by: 1

Related to: 10